Protalix BioTherapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2015 | 83.3% | -542.4% | 1,329.9% |
| FY2016 | 8.7% | -360.5% | -319.2% |
| FY2017 | 19.0% | -163.8% | -395.9% |
| FY2018 | 72.8% | -56.4% | -77.3% |
| FY2019 | 80.1% | -19.6% | -33.4% |
| FY2020 | 82.7% | 4.3% | -10.4% |
| FY2021 | 57.4% | -53.4% | -71.9% |
| FY2022 | 58.9% | -27.3% | -31.3% |
| FY2023 | 64.9% | 16.0% | 12.7% |
| FY2024 | 54.5% | 7.3% | 5.5% |